Abiraterone Acetate Tablet
Product Images NDC 75907-224

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 75907-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Containernc (Containernc)

Label for Abiraterone Acetate Tablets USP 250 mg oral tablets by Dr. Reddys Laboratories Inc. The label indicates 120 tablets per package, includes a warning about handling by pregnant women, storage instructions to keep between 15°C and 30°C, and a caution to keep out of reach of children. The label displays the NDC 75907-224 and barcode, and notes the product is made in India.*

FDA Label Image

Figure1 (Figure1)

A survival curve chart comparing the percentage survival over time in months for patients treated with Abiraterone Acetate versus placebo. The graph shows time to death with Abiraterone Acetate and placebo groups plotted, indicating differences in survival percentages across several months.*

FDA Label Image

Figure2 (Figure2)

A Kaplan-Meier survival curve graph comparing the percentage of subjects without death over months from randomization for Abiraterone Acetate versus placebo. The x-axis represents months from randomization up to 57 months, and the y-axis shows the percentage of subjects without death from 0 to 100%. Two separate lines depict survival probabilities for the placebo group and the Abiraterone Acetate group.*

FDA Label Image

Figure3 (Figure3)

A Kaplan-Meier survival curve chart showing percentage of subjects without radiographic progression or death over months from randomization, comparing Abiraterone Acetate and Placebo groups. The x-axis represents months from randomization, and the y-axis represents percentage of subjects. Two curves are depicted: a solid line for Abiraterone Acetate and a dashed line for Placebo.*

FDA Label Image

Figure4 (Figure4)

A Kaplan-Meier survival curve chart showing the percentage survival of subjects without death over time in months from randomization. The chart compares two groups: Abiraterone Acetate and Placebo, with survival percentages on the y-axis and months on the x-axis. The number of subjects at risk for each group is listed below the x-axis at various time points.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Abiraterone Acetate showing its molecular framework, including steroid rings, methyl groups, an acetate group, and a pyridine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.